DK1146864T3 - pH-uafhængig farmaceutisk formulering med forlænget frisætning - Google Patents
pH-uafhængig farmaceutisk formulering med forlænget frisætningInfo
- Publication number
- DK1146864T3 DK1146864T3 DK00904586T DK00904586T DK1146864T3 DK 1146864 T3 DK1146864 T3 DK 1146864T3 DK 00904586 T DK00904586 T DK 00904586T DK 00904586 T DK00904586 T DK 00904586T DK 1146864 T3 DK1146864 T3 DK 1146864T3
- Authority
- DK
- Denmark
- Prior art keywords
- weight percent
- tablet
- release
- extended
- pharmaceutical formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24467899A | 1999-02-04 | 1999-02-04 | |
PCT/US2000/001954 WO2000045793A1 (en) | 1999-02-04 | 2000-01-26 | Ph independent extended release pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1146864T3 true DK1146864T3 (da) | 2009-05-11 |
Family
ID=22923698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00904586T DK1146864T3 (da) | 1999-02-04 | 2000-01-26 | pH-uafhængig farmaceutisk formulering med forlænget frisætning |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1146864B1 (de) |
JP (2) | JP5420126B2 (de) |
AT (1) | ATE424191T1 (de) |
CA (1) | CA2361496C (de) |
CY (1) | CY1108863T1 (de) |
DE (1) | DE60041691D1 (de) |
DK (1) | DK1146864T3 (de) |
ES (1) | ES2321908T3 (de) |
PT (1) | PT1146864E (de) |
WO (1) | WO2000045793A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6713086B2 (en) | 1998-12-18 | 2004-03-30 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US20020025341A1 (en) * | 1998-12-18 | 2002-02-28 | Yihong Qiu | Controlled release formulation of divalproex sodium |
US6528090B2 (en) | 1998-12-18 | 2003-03-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6511678B2 (en) | 1998-12-18 | 2003-01-28 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6419953B1 (en) | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2002051402A1 (en) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
WO2004071421A2 (en) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds |
WO2007036952A2 (en) | 2005-07-01 | 2007-04-05 | Rubicon Research Pvt Ltd. | Novel sustained release dosage form |
CN102413814A (zh) * | 2009-04-29 | 2012-04-11 | 瑞恩药品公司 | 用于神经保护和治疗神经变性病症的克拉维酸类物质制剂 |
CN107811985B (zh) * | 2016-09-13 | 2021-05-28 | 四川科瑞德制药股份有限公司 | 一种抗癫痫缓释制剂及其制备方法与用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
DE3809764A1 (de) * | 1988-03-23 | 1989-10-05 | Knoll Ag | Mischung aus alginaten und polyacrylaten und deren verwendung |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
US5102668A (en) * | 1990-10-05 | 1992-04-07 | Kingaform Technology, Inc. | Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH |
EP0844870B1 (de) * | 1995-08-17 | 2001-11-21 | Csir | Produkte mit gesteuerter freisetzung |
AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
DK0921793T3 (da) * | 1997-03-11 | 2000-12-18 | Hexal Ag | Faste, ikke-henflydende formuleringer af natriumvalproat |
-
2000
- 2000-01-26 JP JP2000596913A patent/JP5420126B2/ja not_active Expired - Lifetime
- 2000-01-26 CA CA2361496A patent/CA2361496C/en not_active Expired - Fee Related
- 2000-01-26 DK DK00904586T patent/DK1146864T3/da active
- 2000-01-26 PT PT00904586T patent/PT1146864E/pt unknown
- 2000-01-26 WO PCT/US2000/001954 patent/WO2000045793A1/en active Application Filing
- 2000-01-26 AT AT00904586T patent/ATE424191T1/de active
- 2000-01-26 ES ES00904586T patent/ES2321908T3/es not_active Expired - Lifetime
- 2000-01-26 DE DE60041691T patent/DE60041691D1/de not_active Expired - Lifetime
- 2000-01-26 EP EP00904586A patent/EP1146864B1/de not_active Expired - Lifetime
-
2009
- 2009-03-06 CY CY20091100254T patent/CY1108863T1/el unknown
-
2011
- 2011-05-24 JP JP2011116089A patent/JP5420590B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2000045793A1 (en) | 2000-08-10 |
JP2011241218A (ja) | 2011-12-01 |
CY1108863T1 (el) | 2014-07-02 |
EP1146864B1 (de) | 2009-03-04 |
EP1146864A1 (de) | 2001-10-24 |
ATE424191T1 (de) | 2009-03-15 |
CA2361496A1 (en) | 2000-08-10 |
JP2002536318A (ja) | 2002-10-29 |
CA2361496C (en) | 2011-06-07 |
DE60041691D1 (de) | 2009-04-16 |
PT1146864E (pt) | 2009-03-20 |
JP5420126B2 (ja) | 2014-02-19 |
JP5420590B2 (ja) | 2014-02-19 |
ES2321908T3 (es) | 2009-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108863T1 (el) | Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη | |
HUP9800516A2 (hu) | Gyógyszerforma kevéssé oldódó, bázisos gyógyszerhatóanyagok szabályzott felszabadítására | |
DK1028707T3 (da) | Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter | |
RS20070511A (en) | Modified release pharmaceutical compositions and processes thereof | |
KR950702409A (ko) | 방출 조절 모르핀 제제(controlled release morphine preparation) | |
CA2126611A1 (en) | Opiod Formulations Having Extended Controlled Release | |
TNSN98229A1 (fr) | Formulation pharmaceutique orale a liberation prolongee | |
BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
CA2601289A1 (en) | Once-a-day oxycodone formulations | |
HUP0004924A2 (hu) | Ciklodextrineket tartalmazó gyógyászati készítmények | |
EA200200595A1 (ru) | Лекарственная форма с высвобождением лекарства под действием гидрогеля | |
PT1079806E (pt) | Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido | |
DE60038536D1 (de) | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe | |
EP0136103B1 (de) | Amosulalolhydrochlorid-Formulierungen mit lang anhaltender Wirkung | |
JPS6388122A (ja) | 吸収および作用が速やかなサリンダツクまたはサリンダツクナトリウムと塩基の併用剤 | |
EP0966966A3 (de) | Nefazodon enthaltende Dosierungsform | |
US4738850A (en) | Controlled release formulation and method | |
BR0212155A (pt) | Composição farmacêutica | |
CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
SE9603480L (sv) | Beredningsform för svårlösliga läkemedel | |
ES2186207T3 (es) | Metodo para preparacion de formulaciones farmaceuticas. | |
EP0121901B1 (de) | Tabletten mit pH-unabhängiger kontrollierter Freisetzung | |
IT1303753B1 (it) | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. | |
CO4910116A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles | |
TH51543A3 (th) | รูปแบบยาของเนฟาโซโดน |